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Background: Host genetic variations may contribute to disease susceptibility of influenza. IL-1A and IL-1B are
important inflammatory cytokines that mediate the inflammation and initiate the immune response against virus
infection. In this study, we investigated the relationship between single-nucleotide polymorphisms (SNPs) of
Interleukin-1A (IL-1A) and Interleukin-1B (IL-1B) and the susceptibility to 2009 pandemic A/H1N1 influenza (A(H1N1)
pdm09). 167 patients whom were confirmed with A(H1N1)pdm09 and 192 healthy controls were included in this
study. Four SNPs (rs1304037, rs16347, rs17561, rs2071373) in IL1A gene and three SNPs (rs1143623, rs3917345,
rs1143627) in IL1B gene were genotyped by using matrix-assisted laser desorption/ionization time-of-flight
(MALDI-TOF) mass spectrometry platform, and the associations of the genetic variants of IL-1 with susceptibility to
A(H1N1)pdm09 were then assessed.
Results: The polymorphisms of rs17561 in IL1A gene and rs1143627 in IL1B gene were found to be associated with
susceptibility to A(H1N1)pdm09 with P values of 0.003 (OR 2.08, 95% CI 1.27-3.41) and 0.002 (OR 1.62 , 95% CI 1.20-2.18),
respectively. However, no significant difference in allelic frequency was observed for other SNPs between cases and
controls.
Conclusions: This study provides a new insight into pathogenesis of A(H1N1)pdm09, suggesting that genetic variants of
IL-1A and IL-1B may exert a substantial impact on the susceptibility of A(H1N1)pdm09 virus infection.
Keywords: Interleukin-1, H1N1, Influenza, Single-nucleotide polymorphisms (SNPs)Background
The global pandemic caused by the novel A(H1N1)pdm09
was first declared in Mexico and the United States in April
2009, inducing severe morbidity and mortality in a subset
of the population [1]. This novel strain of influenza A
virus is made up of a unique combination of gene seg-
ments from Eurasian swine, human and avian influenza
viruses [2]. Thus, seasonal influenza vaccines do not
confer effective cross-protection against A(H1N1)pdm09
virus infection. While the virulence and evolution of influ-
enza virus have been intensively studied, the impact of* Correspondence: zenggch@mail.sysu.edu.cn
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reproduction in any medium, provided the orhost genetic background on the susceptibility to pandemic
influenza virus infection remains largely unknown.
It has been suggested that the host genetic factors may
affect the susceptibility and progression of microbial infec-
tions [3]. For example, Chinese population-attributable
risk for severe influenza infection was ten-fold greater
than Northern European population-attributable risk be-
cause of the high frequency of rs12252-C in Han Chinese
[4]. Meanwhile, the SNPs in TLR3 [5], CD55 [6], C1q and
FCGR2A [7], TNF [8,9], LTA, IL8 and IL1B [9] were sug-
gested to be connected with the severity of A(H1N1)
pdm09 virus infection.
During influenza virus infection, IL-1B has been demon-
strated to mediate acute pulmonary inflammatory path-
ology [10]. Pro-IL-1B was cleaved by caspase-1 which
was activated through the formation of the NLRP3This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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IL-1A secretion was also regulated by the NLRP3
inflammasome [12,13]. In addition, IL-1A and IL-1B
induced the expression of a variety of inflammatory
mediators, which may initiate the cascade of inflam-
matory responses and induced the activation of T
cells [14,15]. To date, few studies have explored the
association between IL-1 polymorphisms and A/H1N1
susceptibility [9]. Therefore, investigation of whether
the genetic variants in IL-1 impact the susceptibility
to A(H1N1)pdm09 is of great importance.
In this study, we examined 7 SNPs in IL1 gene and
evaluated their association with A(H1N1)pdm09 suscep-
tibility. The results indicated that rs17561 polymorphism
in IL1A gene and rs1143627 polymorphism in IL1B
gene, two novel SNPs of IL-1 gene, contributed to the
susceptibility to A(H1N1)pdm09.
Methods
Study subjects and samples
167 patients with A(H1N1)pdm09 were recruited in
Shenzhen Third People’s Hospital, China during 2009
influenza pandemic period. 167 patients (91 males and
76 females) were included in this study, and the average
age of patients is 22.37 (SD = 11.95). The diagnosis of A
(H1N1)pdm09 was followed the guideline released by
the Ministry of Health of the People’s Republic of China.
192 Healthy donors (HD) were from Shenzhen, China
during the same period, and no occurrence of A(H1N1)
pdm09 was found in the HD during 1 year’s follow-up.
192 health individuals (101 males and 91 females) were
recruited as controls, and the average age of healthy in-
dividuals is 24.53 (SD = 10.29). All subjects were Chinese
Han people whom have received flu vaccine previously.
Venous blood was drawn from all subjects after an over-
night fasting. Blood corpuscles were stored at −80°C
for DNA purification. The study was approved by the
Institutional Review Board of Shenzhen Third People’s
Hospital, and informed consent was obtained from
each participant. There is no significant difference for
the average age and gender distribution between cases
and controls (P >0.05).
DNA extraction and SNP selection
Genomic DNA was obtained from peripheral blood sam-
ples, using the QIAamp DNA Blood Mini kit (Qiagen,
Hilden, Germany) according to the manufacturer’s in-
struction. Isolated DNA was stored at −80°C before
usage. SNPs were selected according to methods de-
scribed previously [16], with focusing on their potential
regulatory roles, such as transcription binding sites in
the promoter region, microRNA target sites in the 3′
untranslated region (UTR), protein phosphorylation sites
in the extrons and other putative regulation sites.To search for the SNPs with alleles that alter the puta-
tive transcription factor binding sites, we scanned the
promoter region of the gene in TRANSFAC database
[17]. For the annotated SNPs in dbSNP129 that are
within 2000 bp upstream to 500 bp downstream of the
IL-1 gene, we extracted their flanking sequence (1-25 bp)
from the dbSNP website (http://www.ncbi.nlm.nih.gov/
projects/SNP/). We then used a PWM_SCAN Algorithm
[18] to scan each sequence in the set to test whether it
had a putative binding site (PBS), using the method de-
scribed previously [19]. To search for the SNPs with al-
leles that alter the putative microRNA target sites, we
first searched the PITA database for the microRNAs that
could target the 3′ UTR region of the IL-1 gene. For the
SNP that is in the target site, we obtained its flanking se-
quence (1-50 bp) from the UCSC genome browser
according to its genomic location. We then tested
whether the change of alleles also changed the
microRNA target interaction by RNA hybridization. In
addition, we used tagging procedure to select SNPs that
cover the IL-1 gene [20], and chose the CHB + JPT
HapMap panel, r2 = 0.8 and default settings for all other
parameters. We also selected several other SNPs in the
IL-1 gene region that were reported to be associated with
disease severity [21-23]. The allelic variant substitution
bases and the allele specific primer sequences were
shown in Table 1.
Genotyping
SNPs’ genotyping was based on analysis of primer exten-
sion products generated from previously amplified gen-
omic DNA using a chip-based MALDI-TOF mass
spectrometry platform (Sequenom, San Diego, CA). The
amplification PCR primer pairs and the extend primers
were designed by MassARRAY assay designer software
v3.1, in combination with manual adjustment (Table 1).
PCR amplification was performed in the HotStar buffer
system (Qiagen, Hilden, Germany). Extend products
were dispensed onto a 384-spot plate, and Thermo
cycling (Applied Biosystems, USA) was initiated at 94°C
for 5 min; followed by 40 cycles of 94°C for 30 s, 55°C for
30 s, 72°C for 30 s; and a final extension of 72°C for 3 min
to amplify identical length products. Following genomic
amplification of the target regions, excess deoxyribonucle-
otide triphosphates were dephosphorylated with 2 μL
shrimp alkaline phosphatase by incubation at 37°C for
60 min, and stopped by inactivation at 85°C for 10 min.
The selected SNPs were analyzed in one primer-
extension reaction, the PCR was then performed at 94°C
for 15 min, 40 cycles of 94°C for 5 s, (52°C for 5 s, and
80°C for 5 s, 5 cycles), followed by a final extension done
at 72°C for 3 min. After desalting extension products for
MALDI-TOF mass spectrometry analysis by the addition
of 16 μL water and 6 mg of clean resin to each sample.
Table 1 Outline of primers for IL1A, IL1B SNP genotyping
Gene SNP ID Polymorphisms Forward primer Reverse primer Un-extension primer
(5′-3′) (5′-3′) (5′-3′)
IL1A rs1304037 A > G ACGTTGGATGTCGATTAAGAGTTCATCAGC ACGTTGGATGAGCCACAGACCTAGGATTTC AGTTCATCAGCAACTTAAAAG
rs16347 DEL > TGAA ACGTTGGATGGTAGGACTTGATTGCAGGTG ACGTTGGATGTTGAGCCAGTAATTGGTCCG TGCAGGTGGAATTGAA
rs17561 G > T ACGTTGGATGGGTTTTAGAAATCATCAAGCC ACGTTGGATGGAATTCGTATTTGATGATCC TCATCAAGCCTAGGTCA
rs2071373 C > T ACGTTGGATGTGATGTGCATTGGCTTCTCC ACGTTGGATGAACATCCTGATGAAGCCTGC TCCCAGAACAGAGCAGAAC
IL1B rs1143623 G > C ACGTTGGATGATGTGCCAGGTATCGTGCTC ACGTTGGATGACCTATTTCCCTCGTGTCTC GCTCGCTCTGCATTAT
rs3917345 DEL > TGGT ACGTTGGATGTGCTGGTGTCTCGGTTAAAG ACGTTGGATGTCTGAGACTCTATCTCTTGG AGAGAAACTGATAACTCTTGGT
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software 4.0.
Statistical analysis
The frequencies of allele and genotype were determined by
direct counting. All SNPs investigated in this study were
tested for Hardy-Weinberg equilibrium. The Pearson χ2
test was used to compare allele and genotype distribution
in cases and controls. Odds ratios (ORs) and their 95%
confidence intervals (CI) were calculated with Miettinen’s
method. Each SNP was calculated under four alternative
models (dominant, recessive, multiplicative and additive),
as previously described [4,24-26]. Bonferroni correction
was used to compare the allelic frequency between partici-
pants with different genotypes. All the statistical proce-
dures were performed with SPSS13.0 software. P <0.05 was
considered to be significant.
Results
Selection and genotyping of IL1A/IL1B SNPs
To choose relevant SNPs for IL1A and IL1B gene, we con-
sidered about 100 known and rare variants, which are pub-
licly available in database (dbSNP: http://www.ncbi.nlm.nih.
gov/SNP/; CYPallele nomenclature: http://www.cypalleles.
ki.se). After bioinformatic analysis and prediction for SNPs
that may influence gene expression or protein structure
and function, a total of 7 SNPs, including 4 in the IL1A
gene (rs17561 G >T, rs1304037 A >G, rs2071373 C >T,
rs16347 DEL >TGAA), and 3 in the IL1B gene (rs1143623
G >C, rs3917345 DEL > TGGT, rs1143627 T >C), were
selected finally. The locations of these SNPs in IL-1 were
shown in Figure 1. Rs2071373 is in the intron 3 and 209 bp
after the extron 3 (the length from the coding sequence
start site to the extron 3 is 96 bp) of IL1A gene. Rs17561 is
in the extron 5 of IL1A gene and 340 bp after coding
sequence (CDS) start site. Rs1304037 is in the 3′UTR of
IL1A gene and 408 bp after CDS terminal site. Rs16347 is
in the 3′UTR of IL1A gene, 922 bp after CDS terminal site
and a 4 bp fraction is missing. 3 SNPs of IL1B gene are all
in the promoter region. Rs1143623 is 1473 bp before the
transcription start site of IL1B gene. Rs3917345 is 798 bp
before the transcription start site of IL1B gene and a 4 bp
fraction is missing. Rs1143627 is 31 bp before the transcrip-
tion start site of IL1B gene. Genotypes of these 7 SNPs
were determined using the MALDI-TOF mass spectrom-
etry platform in a cohort of 167 cases and 192 con-
trols. The intensities of mass signal of rs17561 and
rs1143627 SNPs from three DNA samples analyzed by
MALDI-TOF mass spectrum were shown in Figure 2.
Association of IL1A gene SNPs with A/H1N1 susceptibility
The genotypic frequencies of the two groups in these 4
SNPs were shown in Table 2. The distribution of genotype
in patients with pH1N1/09 and healthy controls werecoincident with Hardy-Weinberg equilibrium (P > 0.05).
The T allele of rs17561 showed a two-fold increase in risk
for influenza compared with the G allele (multiplicative
model, P = 0.003, odds ratio, OR = 2.08, 95% confidence
interval, CI 1.27-3.41). Under the dominant model,
heterozygotes and homozygotes for the T allele had a
two-fold increase of risk for influenza compared with ho-
mozygotes for the G allele (dominant model, P = 0.001,
OR = 2.43, 95% CI 1.42-4.15). However, no significant dif-
ferences in allelic frequencies for other SNPs were found
between cases and controls. Thus, these data suggested
that the rs17561 SNP, located on the extron of IL1A lead-
ing to Ser114Ala mutation, was associated with A(H1N1)
pdm09 susceptibility.
Association of IL1B gene SNPs with A/H1N1 susceptibility
3 SNPs in IL1B were successfully genotyped and consid-
ered for genetic association tests (Table 3), and all these
SNPs were consist with Hardy-Weinberg equilibrium
(P >0.05). The rs1143627 SNP located on 31 base
pairs upstream from the transcription start site of
IL1B gene was evaluated for the association with in-
creased risk of influenza susceptibility. Under the
multiplicative model, the T allele showed an increase
in risk for influenza compared with the C allele (multi-
plicative model, P = 0.002, OR = 1.62, 95% CI 1.20-2.18).
Under the additive model, genotype TT had a two-fold
higher risk for influenza compared with genotype CC
(additive model, P = 0.005, OR = 2.38, 95% CI 1. 92–4.40).
Under the dominant model, heterozygotes and homozy-
gotes for the T allele had a two-fold higher risk for influ-
enza compared with homozygotes for the C allele
(dominant model, P = 0.002, OR = 1.99, 95% CI 1.28-3.09).
Other 2 SNPs in IL1B showed no significant differ-
ences in allelic frequency among cases and controls. Thus,
rs1143627 SNP in IL1B gene showed significant associ-
ation with increased susceptibility to influenza.
Discussion
In this study, we analyzed the genetic factors impacting
the susceptibility to A(H1N1)pdm09. We examined 7
SNPs in IL1A and IL1B genes and evaluated the associ-
ation between SNPs of IL-1 and A(H1N1)pdm09 suscep-
tibility. We found that rs17561 polymorphism in IL1A
gene and rs1143627 polymorphism in IL1B gene con-
tributed to the susceptibility to A(H1N1)pdm09.
In humans, IL-1 exists in two forms, IL-1A (encoded
by IL1A gene) and IL-1B (encoded by IL1B gene), and
both forms of IL-1 locate on chromosome 2 [27]. IL-1A
and IL-1B are inflammatory cytokines that play important
roles in recruitment of the immune and inflammatory
cells and development of adaptive immune responses [28].
Accumulating evidence has suggested that IL-1A and
IL-1B play important roles in innate immunity against
Figure 2 MALDI–TOF mass spectrum–based analysis of rs17561 and rs1143627 SNPs. Typical MALDI-TOF MS spectra from three DNA
samples are shown. Dashed lines mark the unextended primers and product/extended primers. Rs17561 SNP includes GG, GT, and TT genotypes,
and rs1143627 SNP includes CC, TC, and TT genotypes.
Figure 1 Schematic representation of IL-1α and IL-1β genes. (A) is IL-1α and (B) is IL-1β gene. The boxes represent the exons. The black
boxes represent coding sequences and grey boxes represent 3′ or 5′ untranslated regions. SNPs analyzed in this study are marked with an arrow.
The first line following the direction of arrow marking the SNPs shows the SNP name (i.e. rs-number) from NCBI, and the second line shows the
SNP position and the base substitution starting from the start codon.
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Table 2 Distribution of genotype and allele frequencies of IL1A SNP
Gene Different genetics models
IL1A Controls Cases Multiplicative Additive Dominant Recessive
SNP ID Genotype No (%) No (%) P value OR P value OR (95% CI) P value OR (95% CI) P value OR (95% CI)
RS1304037 AA 161 (83.9) 130 (77.8) 0.262 1.32 (0.81-2.15) 0.147 1.48 (0.87-2.51) 0.386 0.38 (0.04-3.69)
AG 28 (14.6) 36 (21.6) 0.223 0.26 (0.03-2.63)
GG 3 (1.5) 1 (0.6) 0.432 0.41 (0.04-4.02)
rs16347 DEL/DEL 81 (42.2) 68 (40.7) 0.482 1.12 (0.82-1.51) 0.778 1.06 (0.70-1.62) 0.323 1.36 (0.74-2.48)
DEL/TGAA 88 (45.8) 73 (43.7) 0.343 1.36 (0.72-2.59)
TGAA/TGAA 23 (12.0) 26 (15.6) 0.367 1.35 (0.70-2.57)
rs17561 GG 166 (86.5) 121 (72.5) 0.003 2.08 (1.27-3.41) 0.001 2.43 (1.42-4.15) 0.646 0.54 (0.05-6.37)
GT 24 (12.5) 45 (26.9) 0.260 0.27 (0.02-3.10)
TT 2 (1.0) 1 (0.6) 0.758 0.69 (0.06-7.66)
rs2071373 CC 80 (41.7) 68 (40.7) 0.443 1.13 (0.83-1.53) 0.856 1.04 (0.68-1.59) 0.194 1.51 (0.81-2.84)
CT 92 (47.9) 74 (44.3) 0.191 1.55 (0.80-3.02)
TT 20 (10.4) 25 (15.0) 0.259 1.47 (0.75-2.88)



















Table 3 Distribution of genotype and allele frequencies of IL1B SNP
Gene 4 statistical models
IL1B Controls Cases Multiplicative Additive Dominant Recessive
SNP ID Genotype No (%) No (%) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI)
rs1143623 GG 57 (29.7) 37 (22.2) 0.106 1.27 (0.95-1.71) 0.105 1.48 (0.92-2.40) 0.318 1.28 (0.79-2.07)
GC 92 (47.9) 85 (50.9) 0.633 1.13 (0.68-1.89)
CC 43 (22.4) 45 (26.9) 0.11 1.61 (0.90-2.90)
rs3917345 DEL/DEL 191 (99.5) 166 (99.4) 0.541 1.15 (0.07-18.47) 0.541 1.15 (0.07-18.55) — —
DEL/TGGT 1 (0.5) 1 (0.6) — —
TGGT/TGGT 0 (0.0) 0 (0.0) — —
rs1143627 TT 84 (43.8) 47 (28.1) 0.002 1.62 (1.20-2.18) 0.002 1.99 (1.28-3.09) 0.063 1.68 (0.97-2.91)
TC 81 (42.2) 84 (50.3) 0.399 1.29 (0.72-2.31)
CC 27(14.1) 36 (21.6) 0.005 2.38 (1.29-4.40)
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http://www.biomedcentral.com/1471-2172/14/37viral infection. Infection of viruses such as, hepatitis
A virus (HAV) [29], epstein-barr virus (EBV) [30],
HIV [31] and human papilloma viruses (hrHPVs) [3],
may activate the extracellular signal and induce pro-
duction of IL-1. Several studies have documented an
early rise in IL-1 in bronchoalveolar lavage (BAL)
fluids or lung homogenates in temporal association
with symptom formation and lung pathology after
infection with A/PR/8/34 H1N1 or A(H1N1)pdm09
[32-34].
In fact, IL1A with rs17561 allele T has been suggested to
be associated with immunopathogenesis of several dis-
eases, including nasal polyposis [22], chronic rhinosinusitis
[23]. Rs17561 polymorphism was related with high levels
of C-reactive protein, which can regulate the severity in-
flammatory response [35]. Interestingly, our result also in-
dicated that rs17561 allele T increased the risk of A
(H1N1)pdm09 susceptibility. In contrast, rs1304037 and
rs16347 locating on 3′UTR, and rs2071373 locating on in-
tron box did not display any association with the suscepti-
bility to A(H1N1)pdm09. The SNP rs17561 represents a
nonsynonymous mutation (Ala114Ser) in IL-1A protein,
suggesting that this mutation may lead to a potential func-
tional variation in host susceptibility to A(H1N1)pdm09.
However, the exact mechanism needs to be further
studied.
During influenza virus infection, the immune response
was triggered by the influenza virus ion channel M2
which was essential for virus entry and replication, lead-
ing to the assembly of inflammasome in macrophages
and dendritic cells (DCs) [36]. Then, the activation of
inflammasome resulted in the cleavage of pro-IL-1B by
caspase-1 and produced the mature form of IL-1B [37].
IL-1B may act with IL-6 to induce IFN-γ production by
T cells [14] and promote RORγt expression and Th-17
polarization of CD4 T cells [15]. The Th-17 effector cells
produced IL-17 and facilitated the recruitment of neu-
trophils and inflammation [38].
Here, we found a significantly high frequency of IL-1B
rs1143627 allele C in A/H1N1 patients, suggesting the
hosts with allele C were more susceptible to this virus
infection. Importantly,the frequency of the rs1143627
allele C is quite rich in Han Chinese (minor allele fre-
quency = 0.476). Thus, elucidation of the underlying
mechanism of the polymorphism of rs1143627 is of great
importance for in-depth understanding of the susceptibil-
ity of influenza in Chinese population. Rs1143627 poly-
morphism involved the variation of IL-1B −31 allele C to
T and is located on the TATA box of IL1B gene promoter
region, which has been demonstrated to be a critical motif
partially determining IL-1B transcriptional efficiency [39].
Furthermore, the rs1143627 and its franking sequences
can be bound by transcription factors, including c/EBPβ,
TBP and Spi-1 [40,41]. Electrophoretic mobility shift assay(EMSA) analysis suggested that c/EBPβ confers a much
higher affinity to rs1143627-C probe than to T probe [40].
Several reports have shown that the allele T of rs1143627
enhanced IL-1B protein expression [40,42], and T-allele of
rs1143627 was considered to be a pro-inflammatory allele
[41]. People who carry allele T had a higher IL-1B expres-
sion that may promote the production of IFN-γ, which
plays an important role in virus clearance [14]. IL-1B may
also facilitate the differentiation and proliferation of pro-
inflammatory cells such as Th-17 in humans [15,43]. In
contrast, the expression of IL-1B may be much lower in
people who carry allele C, leading to weaker immune re-
sponse during viral infection.
Thus, it is possible that IL1B SNP rs1143627 C allele
has a lower binding affinity to c/EBPβ and reduced levels
of IL-1B expression, which may therefore weaken the in-
flammatory response of Th-17 and Th-1 cells in humans
during influenza infection. A cohort of study with a lar-
ger population size is needed to further confirm the as-
sociation of IL1A rs17561 allele T and IL1B rs1143627
allele C with an increased risk for the susceptibility to A
(H1N1)pdm09. Functional studies will also be needed to
further investigate the role and mechanism of genetic
variants of IL-1 on the impact of susceptibility to A
(H1N1)pdm09.
Conclusion
IL1A rs17561 allele T and IL1B rs1143627 allele C may
confer an increased risk for the susceptibility to A
(H1N1)pdm09. Thus, this study provides a new insight
into the immunopathogenesis of influenza A virus infec-
tion in humans.
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